Sangamo Biosciences (SGMO)
This is an interesting biopharmaceutical company
involved in the development of drugs against HIV at the clinical stage. They
have been developing and commercializing the use of zinc finger DNA binding
proteins (ZFPs) and modifying them to become nucleases (cut nucleic acids).
